(Q35653537)

9 August 2017

title

Diurnal and nocturnal drooling in Parkinson's disease (English)

1 reference

9 August 2017

J G Kalf

1

1 reference

9 August 2017

B R Bloem

series ordinal

2

1 reference

9 August 2017

M Munneke

series ordinal

3

1 reference

9 August 2017

publication date

23 June 2011

1 reference

9 August 2017

1 reference

9 August 2017

volume

259

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

119-123

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-011-6138-2

9 August 2017

exact match

0 references

cites work

Prevalence and definition of drooling in Parkinson's disease: a systematic review

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251785

Parkinson's disease: clinical features and diagnosis

12 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251785

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251785

Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.

12 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

Debilitating consequences of drooling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

The impact of and the factors associated with drooling in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

Human adult deglutition during sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

Quantitative study of salivary secretion in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

Patient-reported autonomic symptoms in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6138-2

Reproducibility and validity of patient-rated assessment of speech, swallowing, and saliva control in Parkinson's disease

21 January 2018

1 reference

12 December 2020

Pathophysiology of diurnal drooling in Parkinson's disease

1 reference

12 December 2020

Impact of drooling in Parkinson's disease

1 reference

12 December 2020

Is drooling secondary to a swallowing disorder in patients with Parkinson's disease?

1 reference

12 December 2020

10.1007/S00415-011-6138-2

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference